March 26, 2022
Advances in our Understanding of the Management of MDS
Advances in our Understanding of the Management of MDS
This webinar will describe recent advances in our understanding of the management of myelodysplastic syndromes and related myeloid neoplasms, and how these advances are being translated into more effective treatments for these patients.
Speaker
Michael Kenneth Keng, MD
Our Supporters
Thank you to Taiho Oncology, Jazz Pharmaceuticals, Novartis, Bristol-Myers Squibb, and VJHemonc for supporting this initiative.